SMTL ID : 9don.2 (1 other biounit)

Crystal structure of eIF4e in complex with Compound 5-PA

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 2.09 Å

Oligo State

monomer

Ligands

1 x 01: 2-[3-[[2-azanyl-7-[(5-chloranyl-1-benzofuran-2-yl)methyl]-6-oxidanylidene-1~{H}-purin-9-yl]methyl]phenyl]ethylphosphonic acid

01.1: 17 residues within 4Å: Chain A: W.20, F.21, F.22, W.30, L.34, D.64, S.66, P.74, M.75, W.76, E.77, R.86, V.127, N.129, K.136, W.140, T.177 19 PLIP interactions: 19 interactions with chain A Hydrophobic interactions: A:F.22, A:D.64, A:P.74, A:V.127, A:W.140, A:T.177 Hydrogen bonds: A:W.76, A:R.86, A:K.136 Salt bridges: A:E.77 pi-Stacking: A:W.30, A:W.30, A:W.30, A:W.30, A:W.76, A:W.76, A:W.76 pi-Cation interactions: A:W.30 Halogen bonds: A:W.20

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Cardenas, E.L. et al., Second-Generation Cap Analogue Prodrugs for Targeting Aberrant Eukaryotic Translation Initiation Factor 4E Activity in Cancer. Acs Med.Chem.Lett. (2025)

Release Date

2025-01-29

Peptides

Eukaryotic translation initiation factor 4E: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
B

Eukaryotic translation initiation factor 4E

Related Entries With Identical Sequence